- Home
- QCRH vs TNDM Comparison
QCRH vs TNDM Comparison
Compare QCRH & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QCRH
- TNDM
- Stock Information
- Founded
- QCRH 1993
- TNDM 2006
- Country
- QCRH United States
- TNDM United States
- Employees
- QCRH N/A
- TNDM N/A
- Industry
- QCRH Major Banks
- TNDM Medical/Dental Instruments
- Sector
- QCRH Finance
- TNDM Health Care
- Exchange
- QCRH Nasdaq
- TNDM Nasdaq
- Market Cap
- QCRH 1.1B
- TNDM 1.1B
- IPO Year
- QCRH 1993
- TNDM 2013
- Fundamental
- Price
- QCRH $72.23
- TNDM $15.59
- Analyst Decision
- QCRH Buy
- TNDM Buy
- Analyst Count
- QCRH 3
- TNDM 13
- Target Price
- QCRH $86.67
- TNDM $32.15
- AVG Volume (30 Days)
- QCRH 107.4K
- TNDM 1.6M
- Earning Date
- QCRH 07-23-2025
- TNDM 08-06-2025
- Dividend Yield
- QCRH 0.33%
- TNDM N/A
- EPS Growth
- QCRH N/A
- TNDM N/A
- EPS
- QCRH 6.65
- TNDM N/A
- Revenue
- QCRH $324,275,000.00
- TNDM $982,951,000.00
- Revenue This Year
- QCRH N/A
- TNDM $8.91
- Revenue Next Year
- QCRH $7.10
- TNDM $11.04
- P/E Ratio
- QCRH $10.84
- TNDM N/A
- Revenue Growth
- QCRH N/A
- TNDM 27.65
- 52 Week Low
- QCRH $60.54
- TNDM $15.17
- 52 Week High
- QCRH $96.08
- TNDM $48.24
- Technical
- Relative Strength Index (RSI)
- QCRH 62.32
- TNDM 27.20
- Support Level
- QCRH $71.96
- TNDM $15.17
- Resistance Level
- QCRH $73.43
- TNDM $17.12
- Average True Range (ATR)
- QCRH 1.90
- TNDM 0.99
- MACD
- QCRH 0.55
- TNDM -0.31
- Stochastic Oscillator
- QCRH 82.25
- TNDM 6.99
About QCRH QCR Holdings Inc.
QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely QCBT, CRBT, CSB, and GB. It generates revenue in the form of interest.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.